Figures
- Fig. 1—
A Kaplan–Meier plot showing estimated proportion of treatment success (cure plus treatment completion) according to the drug-resistance profile in Estonia, Germany, Italy and the Russian Federation. ········: other mutidrug-resistant tuberculosis (MDR-TB) cases; - - - - -: MDR-TB cases resistant to all first-line drugs; –––––: extensively drug-resistant tuberculosis cases.
Tables
- Table 1—
Outcomes of extensively drug-resistant tuberculosis (XDR-TB) and multidrug-resistant tuberculosis (MDR-TB) cases in Estonia, Germany, Italy and the Russian Federation
Treatment success Died Default Failure Transferred Total patients completing treatment XDR-TB# 22 (39.3) 14 (25.0) 8 (14.3) 12 (21.4) 0 (0.0) 56 MDR-TB resistant to all first-line drugs¶ 123 (53.7) 35 (15.3) 39 (17.0) 29 (12.7) 3 (1.3) 229 Other MDR-TB+ 42 (66.7) 8 (12.7) 10 (15.9) 3 (4.8) 0 (0.0) 63 Total 187 (53.7) 57 (16.4) 57 (16.4) 44 (12.6) 3 (0.9) 348 Data are presented as n (%) or n. #: resistance to at least rifampin and isoniazid (definition of MDR-TB) in addition to any fluoroquinolone, and at least one of the three injectable anti-TB drugs (capreomycin, kanamycin and amikacin); ¶: cases resistant to isoniazid, rifampicin ethambutol, streptomycin and, when tested, pyrazinamide; +: cases susceptible to at least one first-line anti-TB drug. Default and transferred cases included in this table were removed from the analysis presented in the text.
